• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Gevo Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8/29/24 9:00:25 AM ET
    $GEVO
    Major Chemicals
    Industrials
    Get the next $GEVO alert in real time by email
    false 0001392380 0001392380 2024-08-28 2024-08-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): August 28, 2024

     

     

    Gevo, Inc.

    (Exact name of registrant as specified in its charter)

     

     

    Delaware 001-35073 87-0747704
    (State or other jurisdiction (Commission File Number) (IRS Employer
    of incorporation)   Identification No.)

     

    345 Inverness Drive South, Building C, Suite 310
    Englewood
    , CO 80112

    (Address of principal executive offices) (Zip Code)

     

    Registrant’s telephone number, including area code: (303) 858-8358

     

    N/A

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading symbol   Name of exchange on which registered
    Common Stock, par value $0.01 per share   GEVO   Nasdaq Capital Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

    Item 3.01.Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

     

    On August 28, 2024, Gevo, Inc. (the “Company”) received a letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) granting the Company an additional 180 calendar days, or until February 24, 2025, to regain compliance with the $1.00 per share minimum bid price requirement required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Marketplace Rule 5550(a)(2) (the “Minimum Bid Price Rule”).

     

    As previously reported, on February 29, 2024, the Company received a notification letter from the Staff advising the Company that for 30 consecutive trading days preceding the date of the notice from Nasdaq, the bid price of the Company’s common stock had closed below the $1.00 per share minimum required for continued listing on the Nasdaq Capital Market pursuant to the Minimum Bid Price Rule. The Company was provided an initial 180 calendar days, or until August 27, 2024, to regain compliance with the Minimum Bid Price Rule. The Nasdaq determination to grant the second compliance period was based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the bid price requirement, and the Company’s written notice of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary.

     

    To regain compliance, the bid price of the Company’s common stock must close at or above $1.00 per share for a minimum of ten consecutive business days at any time during the second 180-day compliance period. The Company intends to monitor the closing bid price of its common stock and may, if appropriate, consider implementing available options, including submitting a reverse stock split for approval by the Company’s stockholders. If a reverse stock split is approved by the stockholders of the Company, the Company’s Board of Directors will consider whether a reverse stock split is necessary and would facilitate the Company regaining compliance with the Minimum Bid Price Rule by February 24, 2025. There can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Rule or maintain compliance with the other listing requirements necessary for the Company to maintain the listing of its common stock on the Nasdaq Capital Market.

     

    The notice from Nasdaq has no effect on the listing of the Company’s common stock at this time and the Company’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “GEVO”.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      GEVO, INC.
         
    Dated: August 29, 2024 By: /s/ E. Cabell Massey
        E. Cabell Massey
        Vice President, Legal and Corporate Secretary

     

     

     

    Get the next $GEVO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GEVO

    DatePrice TargetRatingAnalyst
    12/1/2025$3.00Outperform
    Northland Capital
    8/21/2023$2.00Market Perform
    Northland Capital
    12/14/2022$2.25Neutral
    UBS
    10/19/2022$2.29Hold
    Jefferies
    2/9/2022$5.00Buy
    Citigroup
    8/24/2021$10.00Buy
    Stifel
    More analyst ratings

    $GEVO
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Gevo Inc.

    SCHEDULE 13G/A - Gevo, Inc. (0001392380) (Subject)

    3/26/26 6:37:11 PM ET
    $GEVO
    Major Chemicals
    Industrials

    Gevo Inc. filed SEC Form 8-K: Leadership Update

    8-K - Gevo, Inc. (0001392380) (Filer)

    3/16/26 4:02:00 PM ET
    $GEVO
    Major Chemicals
    Industrials

    SEC Form 144 filed by Gevo Inc.

    144 - Gevo, Inc. (0001392380) (Subject)

    3/10/26 4:01:10 PM ET
    $GEVO
    Major Chemicals
    Industrials

    $GEVO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Shafer Andrew

    4 - Gevo, Inc. (0001392380) (Issuer)

    4/2/26 5:35:06 PM ET
    $GEVO
    Major Chemicals
    Industrials

    SEC Form 4 filed by Ryan Christopher Michael

    4 - Gevo, Inc. (0001392380) (Issuer)

    4/1/26 5:35:05 PM ET
    $GEVO
    Major Chemicals
    Industrials

    Director Mize Gary W. sold $250,078 worth of shares (107,100 units at $2.33), decreasing direct ownership by 28% to 281,226 units (SEC Form 4)

    4 - Gevo, Inc. (0001392380) (Issuer)

    3/12/26 5:35:10 PM ET
    $GEVO
    Major Chemicals
    Industrials

    $GEVO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Gevo Appoints Key Executive Team Members

    ENGLEWOOD, Colo., April 01, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), a leader in renewable fuels, chemicals, and carbon management, today announced the appointments of Kyle James as Chief Commercial Officer and Dave Kettner as General Counsel, further supporting Gevo's broader leadership transition. The executive additions round out newly appointed Chief Executive Officer Paul Bloom's executive team, increasing expertise across renewable fuels, chemicals and value-driven commercial strategies and expanding the company's legal expertise and first-hand experience scaling renewable fuels and technology businesses. "I am excited to welcome Kyle and Dave to Gevo. Kyle's deep experien

    4/1/26 9:00:00 AM ET
    $GEVO
    Major Chemicals
    Industrials

    Gevo Announces it is Developing Plans for Major Ethanol Expansion at Richardton, North Dakota Facility

    ENGLEWOOD, Colo., March 30, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), a leader in sustainable fuels and carbon management, today announced that it is developing plans for a potential expansion at the site of its Gevo North Dakota facility ("GND") in Richardton, North Dakota by adding a second ethanol production facility with targeted production capacity of up to 75 million gallons per year ("MGPY") of low-carbon ethanol. "As we pursue strategic opportunities for accretive growth, the expansion of production at Gevo North Dakota is at the top of our list," said Paul Bloom, President of Gevo. "We believe GND is one of the best sites in the U.S., in a pro-agriculture and pro-energy

    3/30/26 9:00:00 AM ET
    $GEVO
    Major Chemicals
    Industrials

    Gevo Positioned to Accelerate Global Expansion Through Licensing and Franchise Development Strategy

    ENGLEWOOD, Colo., March 24, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), a leader in sustainable fuels and carbon management, today highlights the strategic value of its intellectual property portfolio. The company references the significant potential growth opportunities created by its proprietary technology platform for synthetic aviation fuel ("SAF"), other renewable hydrocarbons and chemicals, and its industry-leading carbon management system, all of which are believed to offer enormous potential on a global scale. "We are developing the playbook containing Gevo's intellectual property and business system that can be replicated globally," said Paul Bloom, president Gevo. "We bel

    3/24/26 9:00:00 AM ET
    $GEVO
    Major Chemicals
    Industrials

    $GEVO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Northland Capital initiated coverage on Gevo with a new price target

    Northland Capital initiated coverage of Gevo with a rating of Outperform and set a new price target of $3.00

    12/1/25 9:35:34 AM ET
    $GEVO
    Major Chemicals
    Industrials

    Northland Capital initiated coverage on Gevo with a new price target

    Northland Capital initiated coverage of Gevo with a rating of Market Perform and set a new price target of $2.00

    8/21/23 9:21:52 AM ET
    $GEVO
    Major Chemicals
    Industrials

    UBS initiated coverage on Gevo with a new price target

    UBS initiated coverage of Gevo with a rating of Neutral and set a new price target of $2.25

    12/14/22 7:48:29 AM ET
    $GEVO
    Major Chemicals
    Industrials

    $GEVO
    Leadership Updates

    Live Leadership Updates

    View All

    Gevo Appoints Key Executive Team Members

    ENGLEWOOD, Colo., April 01, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), a leader in renewable fuels, chemicals, and carbon management, today announced the appointments of Kyle James as Chief Commercial Officer and Dave Kettner as General Counsel, further supporting Gevo's broader leadership transition. The executive additions round out newly appointed Chief Executive Officer Paul Bloom's executive team, increasing expertise across renewable fuels, chemicals and value-driven commercial strategies and expanding the company's legal expertise and first-hand experience scaling renewable fuels and technology businesses. "I am excited to welcome Kyle and Dave to Gevo. Kyle's deep experien

    4/1/26 9:00:00 AM ET
    $GEVO
    Major Chemicals
    Industrials

    Gevo Strengthens Operational Leadership Amid Ongoing Growth and Succession Planning

    ENGLEWOOD, Colo., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), a leader in renewable fuels and chemicals, and carbon management, today announced the addition of agricultural industry veteran Greg Hanselman as executive vice president, operations and engineering. Mr. Hanselman's hire is part of Gevo's ongoing growth and succession planning, as Chris Ryan, Gevo's long-time chief operating officer, is planning to retire from the company in June of 2026. Mr. Hanselman comes to Gevo from previous roles in global agribusiness leadership as vice president of global engineering for Ingredion (NYSE:INGR), and as senior vice president of global manufacturing for Tate & Lyle, both lea

    1/5/26 9:00:00 AM ET
    $GEVO
    $INGR
    Major Chemicals
    Industrials
    Packaged Foods
    Consumer Staples

    Gevo Names Paul Bloom as Incoming CEO to Succeed Long-Time Leader Patrick Gruber Who Will Retire on April 1, 2026

    ENGLEWOOD, Colo., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), a leader in renewable fuel and chemicals, and carbon management, today announced a strategic leadership transition designed to position the company for continued growth and innovation. Effective December 9, 2025, Dr. Paul Bloom has been appointed President of Gevo, Inc. and a director on Gevo's Board of Directors. Gevo's long-standing Chief Executive Officer and board member, Dr. Patrick Gruber, has assumed the role of Executive Chair of the Board. Board Chairman William H. Baum has moved into the role of lead independent director. As part of the succession plan, Dr. Gruber will continue as Chief Executive Office

    12/15/25 9:00:00 AM ET
    $GEVO
    Major Chemicals
    Industrials

    $GEVO
    Financials

    Live finance-specific insights

    View All

    Gevo Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

    ENGLEWOOD, Colo., March 05, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) ("Gevo", the "Company", "we", "us" or "our"), a leader in renewable fuels and chemicals as well as carbon management, today announced financial results for the fourth quarter and full year ended December 31, 2025 and provided an update on operating performance, cash flow, and progress across its carbon management and synthetic aviation fuel ("SAF") growth platform. A quarterly earnings presentation of the financial results will also be posted to the Company's website at https://investors.gevo.com/news-events/events-presentations. Fourth Quarter and Full Year 2025 Highlights We achieved positive cash flow from o

    3/5/26 4:01:00 PM ET
    $GEVO
    Major Chemicals
    Industrials

    Gevo to Report Fourth Quarter 2025 Financial Results on March 5, 2026

    ENGLEWOOD, Colo., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) announced today that it will host a conference call on March 5, 2026, at 4:30 p.m. ET (2:30 p.m. MT) to report its financial results for the fourth quarter that ended December 31, 2025. To participate in the live call, please register through the following event weblink: https://register-conf.media-server.com/register/BIfdb403c2e64c49cb8424353313763f3e After registering, participants will be provided with a dial-in number and pin. To listen to the conference call (audio only), please register through the following event weblink: https://edge.media-server.com/mmc/p/yw6ggb9k A webcast replay will be available tw

    2/13/26 9:00:00 AM ET
    $GEVO
    Major Chemicals
    Industrials

    Gevo Reports Third Quarter 2025 Financial Results

    ENGLEWOOD, Colo., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO) ("Gevo", the "Company", "we", "us" or "our"), a leading developer of cost-effective, renewable hydrocarbon fuels and chemicals that also can deliver significant carbon emission abatement, today announced financial results for the third quarter ended September 30, 2025. The Company reported a $3.7 million loss from operations and positive Adjusted EBITDA1 of approximately $6.7 million for the third quarter. This marks a second consecutive quarter of positive Adjusted EBITDA for the Company. Recent Corporate Highlights Consistent Performance: Gevo reported a $3.7 million loss from operations for the three months e

    11/10/25 4:01:00 PM ET
    $GEVO
    Major Chemicals
    Industrials

    $GEVO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Gevo Inc.

    SC 13G/A - Gevo, Inc. (0001392380) (Subject)

    11/12/24 4:02:11 PM ET
    $GEVO
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Gevo Inc.

    SC 13G/A - Gevo, Inc. (0001392380) (Subject)

    11/4/24 11:58:10 AM ET
    $GEVO
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Gevo Inc.

    SC 13G/A - Gevo, Inc. (0001392380) (Subject)

    7/8/24 4:32:39 PM ET
    $GEVO
    Major Chemicals
    Industrials